XML 55 R16.htm IDEA: XBRL DOCUMENT  v2.3.0.11
Note 11 Stock-Based Compensation
9 Months Ended
Jul. 02, 2011
Share-based Compensation [Abstract]  
Disclosure of Compensation Related Costs, Share-based Payments [Text Block]
Stock-Based Compensation
 
Stock compensation expense by function and type of instrument was as follows:


 
Three Months Ended
 
Nine Months Ended
 
July 2,

2011
 
July 3,

2010
 
July 2,

2011
 
July 3,

2010
 
(In thousands)
Cost of sales
$
1,773


 
$
487


 
$
3,825


 
$
4,593


Selling, general and administrative
4,208


 
2,215


 
9,998


 
7,910


Research and development
75


 
(335
)
 
157


 
(132
)
Restructuring
914


 


 
914


 


Total
$
6,970


 
$
2,367


 
$
14,894


 
$
12,371






 
Three Months Ended
 
Nine Months Ended
 
July 2,

2011
 
July 3,

2010
 
July 2,

2011
 
July 3,

2010
 
(In thousands)
Stock options
$
5,497


 
$
3,488


 
$
10,908


 
$
10,180


Restricted stock units
1,473


 
(1,121
)
 
3,986


 
2,191


Total
$
6,970


 
$
2,367


 
$
14,894


 
$
12,371






As of July 2, 2011, an aggregate of 15.9 million shares were authorized for future issuance and 3.0 million shares of common stock were available for grant under the Company's stock plans, which include stock options and restricted stock awards and units.
Stock Options


Assumptions used to estimate the fair value of stock options granted were as follows:


 
Three Months Ended
 
Nine Months Ended
 
July 2,

2011
 
July 3,

2010
 
July 2,

2011
 
July 3,

2010
Volatility
90.6
%
 
81.2
%
 
85.0
%
 
81.3
%
Risk-free interest rate
1.6
%
 
2.4
%
 
1.7
%
 
2.4
%
Dividend yield
%
 
%
 
%
 
%
Expected life of options (years)
4.0


 
5.0


 
4.7


 
5.0






Stock option activity was as follows:
 
Number of
Shares
 
Weighted-
Average
Exercise Price
($)
 
Weighted-
Average
Remaining
Contractual
Term
(Years)
 
Aggregate
Intrinsic
Value of
In-The-Money
Options
($)
 
(In thousands)
 
 
 
 
 
(In thousands)
Outstanding, October 2, 2010
11,078


 
14.39


 
7.44


 
35,417


Granted
788


 
11.23


 
 
 
 
Exercised/Cancelled/Forfeited/Expired
(388
)
 
19.17


 
 
 
 
Outstanding, January 1, 2011
11,478


 
14.01


 
7.38


 
35,587


Granted
861


 
15.90


 
 
 
 
Exercised/Cancelled/Forfeited/Expired
(743
)
 
12.95


 
 
 
 
Outstanding, April 2, 2011
11,596


 
14.22


 
7.32


 
28,698


Granted
90


 
10.14


 
 
 
 
Exercised/Cancelled/Forfeited/Expired
(658
)
 
19.89


 
 
 
 
Outstanding, July 2, 2011
11,028


 
13.85


 
7.12


 
21,190


Vested and expected to vest, July 2, 2011
10,068


 
14.34


 
6.97


 
18,756


Exercisable, July 2, 2011
6,546


 
17.36


 
6.11


 
9,817






The weighted-average grant date fair value of stock options granted during the three and nine months ended July 2, 2011 was $6.56 and $8.87, respectively. The weighted-average grant date fair value of stock options granted during the three and nine months ended July 3, 2010 was $11.06 and $6.53, respectively. The aggregate intrinsic value in the preceding table represents the total pre-tax intrinsic value of in-the-money options that would have been received by the option holders had all option holders exercised their options at the Company's closing stock price on the date indicated.


As of July 2, 2011, unrecognized compensation expense related to stock options was $23.3 million, and is expected to be recognized over a weighted average period of 3.6 years.


Restricted Stock Units


The Company grants restricted stock units to executive officers, directors and certain management employees. These units vest over periods ranging from one to four years and are automatically exchanged for shares of common stock at the vesting date. Compensation expense associated with these units is recognized ratably over the vesting period.


As of July 2, 2011, unrecognized compensation expense related to restricted stock units was $15.5 million, and is expected to be recognized over a weighted average period of 2.4 years.


Activity with respect to the Company's non-vested restricted stock units was as follows:


 
Number of
Shares
 
Weighted-
Average Grant Date
Fair Value
($)
 
Weighted-
Average
Remaining
Contractual
Term
(Years)
 
Aggregate
Intrinsic
Value
($)
 
(In thousands)
 
 
 
 
 
(In thousands)
Outstanding, October 2, 2010
938


 
9.78


 
2.12


 
10,200


Granted
784


 
11.23


 
 
 
 
Vested/Cancelled
(38
)
 
13.30


 
 
 
 
Outstanding, January 1, 2011
1,684


 
10.41


 
2.13


 
18,744


Granted
445


 
15.91


 
 
 
 
Vested/Cancelled
(44
)
 
17.77


 
 
 
 
Outstanding, April 2, 2011
2,085


 
11.43


 
2.04


 
21,901


Granted
25


 
10.56


 
 
 
 
Vested/Cancelled
(280
)
 
10.40


 
 
 
 
Outstanding, July 2, 2011
1,830


 
11.57


 
1.82


 
17,040


Expected to vest, July 2, 2011
1,236


 
11.90


 
1.82


 
11,510